Korean Journal of Veterinary Research (대한수의학회지)

The Korean Society of Veterinary Science (대한수의학회)
권호 표지
DOI QR코드

DOI QR Code

Long-circulating and target-specific distributions of cyanine 5.5-labeled hyaluronic acid nanoparticles in mouse organs during 28 days after a single administration

  • Yun, Tae Sik (College of Veterinary Medicine and Veterinary Medical Center, Chungbuk National University) ;
  • Lin, Chunmei (College of Chinese Medicinal Materials, Jilin Agricultural University) ;
  • Yon, Jung-Min (College of Veterinary Medicine and Veterinary Medical Center, Chungbuk National University) ;
  • Park, Seul Gi (College of Veterinary Medicine and Veterinary Medical Center, Chungbuk National University) ;
  • Gwon, Lee Wha (College of Veterinary Medicine and Veterinary Medical Center, Chungbuk National University) ;
  • Lee, Jong-Geol (College of Veterinary Medicine and Veterinary Medical Center, Chungbuk National University) ;
  • Baek, In-Jeoung (Asan Institute for Life Sciences, University of Ulsan College of Medicine) ;
  • Nahm, Sang-Seop (College of Veterinary Medicine, Konkuk University) ;
  • Lee, Beom Jun (College of Veterinary Medicine and Veterinary Medical Center, Chungbuk National University) ;
  • Yun, Young Won (College of Veterinary Medicine and Veterinary Medical Center, Chungbuk National University) ;
  • Nam, Sang-Yoon (College of Veterinary Medicine and Veterinary Medical Center, Chungbuk National University)
  • Received : 2018.10.06
  • Accepted : 2018.12.10
  • Published : 2018.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Although hyaluronic acid (HA) has been developed as a nanoparticle (NP; 320-400 nm) for a drug delivery system, the tissue targeting efficacy and the pharmacokinetics of HA-NPs are not yet fully understood. After a dose of 5 mg/kg of cyanine 5.5-labeled HA-NPs or HA-polymers was intravenously administrated into mice, the fluorescence was measured from 0.5 h to 28 days. The HA-NPs fluorescence was generally stronger than that of HA-polymers, which was maintained at a high level over 7 days in vivo, after which it gradually decreased. Upon ex vivo imaging, liver, spleen, kidney, lung, testis and sublingual gland fluorescences were much higher than that of other organs. The fluorescence of HA-NPs in the liver, spleen and kidney was highest at 30 min, where it was generally maintained until 4 h, while it drastically decreased at 1 day. However, the fluorescence in the liver and spleen increased sharply at 7 days relative to 3 days, then decreased drastically at 14 days. Conversely, the fluorescence of HA-polymers in the lymph node was higher than that of HA-NPs. The results presented herein may have important clinical implications regarding the safety of as self-assembled HA-NPs, which can be widely used in biomedical applications.

Keywords

TSSOBU_2018_v58n4_183_f0001.png 이미지

Fig. 1. In vivo fluorescence images of Cy5.5-labeled HA-NPs (A) and Cy5.5-labeled HA-polymers (B) in the whole body (n = 6) at 0.5 h, 2 h, 4 h, 1 day (d), 3 d, 7 d, 14 d, and 28 d. Tail vein injection of Cy5.5-labeled HA-NPs or HA-polymers (5 mg/kg) in normal hairless mouse. The fluorescence of HA-NPs was much stronger than that of HA-polymers and was maintained longer within the experimental period relative to HA-polymers. The liver and urinary bladder were the main organs that showed strong fluorescence in both groups. Becoming yellow indicates a higher intensity of fluorescence at 680 nm. Normal, untreated mice.

TSSOBU_2018_v58n4_183_f0002.png 이미지

Fig. 2. Ex vivo fluorescence images of Cy5.5-labeled HA-NPs (A) and Cy5.5-labeled HA-polymers (B) in different organs (brain, thymus, sublingual gland, heart, lung, liver, spleen, kidney, adrenal gland, testis and epididymis; n = 6) at 0.5 h, 2 h, 4 h, 1 d, 3 d, 7 d, 14 d, and 28 d. Tail vein injection of Cy5.5-labeled HA-NPs or HA-polymers (5 mg/kg) in normal ICR mice. Generally, the overall fluorescence of HA-NPs was stronger than that of HA-polymers and was maintained longer during the experimental period. The liver, spleen, kidney and lung were the main organs that showed strong fluorescence in both groups. Becoming yellow indicates a higher intensity of fluorescence at 680 nm. 1, brain; 2, sublingual glands; 3, thymus; 4, heart; 5, lung; 6, stomach; 7, liver; 8, spleen; 9, adrenal glands; 10, kidneys; 11, testes; 12, epididymes.

TSSOBU_2018_v58n4_183_f0003.png 이미지

Fig. 3. Fluorescence intensity (106 photons/sec/cm2) of total organs from 0.5 h to 28 d after injection of 0.5 mg/kg of Cy5.5-labeled HA-NPs (A) or Cy5.5-labeled HA-polymers (B). The main organs that showed a high intensity of fluorescence were the liver, lung, spleen, kidney, testis and sublingual gland in both groups. Generally, the intensity of fluorescence peaked within 4 h, then decreased gradually with time. The intensity of Cy5.5-labeled HA-NPs (A) was much stronger than that of Cy5.5-labeled HA-polymers (B). Data are expressed as the means ± SE (n = 6).

TSSOBU_2018_v58n4_183_f0004.png 이미지

Fig. 4. Fluorescence intensity (106 photons/sec/cm2) in the liver (A), spleen (B), kidney (C), lung (D), testis (E) and lymph node (F) from 0.5 h to 28 d after injection of 0.5 mg/kg of Cy5.5-labeled HA-NPs or Cy5.5-labeled HA-polymers. The intensities of Cy5.5-labeled HA-NPs were much stronger level than those of Cy5.5-labeled HA-polymers. Generally, the intensity of fluorescence peaked within 4 h, then decreased gradually thereafter. However, the lymph node showed more powerful intensities of fluorescence in HApolymers within the experimental period than HA-NPs. ap < 0.05 between HA-NPs and HA-polymers. b,cp < 0.05 compared with the intensity of 0.5 h. Data are expressed as the means ± SE (n = 6).

References

  1. Arpicco S, Milla P, Stella B, Dosio F. Hyaluronic acid conjugates as vectors for the active targeting of drugs, genes and nanocomposites in cancer treatment. Molecules 2014, 19, 3193-3230. https://doi.org/10.3390/molecules19033193
  2. Battistini FD, Olivera ME, Manzo RH. Equilibrium and release properties of hyaluronic acid-drug complexes. Eur J Pharm Sci 2013, 49, 588-594. https://doi.org/10.1016/j.ejps.2013.04.023
  3. Choi KY, Chung H, Min KH, Yoon HY, Kim K, Park JH, Kwon IC, Jeong SY. Self-assembled hyaluronic acid nanoparticles for active tumor targeting. Biomaterials 2010, 31, 106-114. https://doi.org/10.1016/j.biomaterials.2009.09.030
  4. Choi KY, Min KH, Na JH, Choi K, Kim K, Park JH, Kwon IC, Jeong SY. Self-Assembled hyaluronic acid nanoparticles as a potential drug carrier for cancer therapy: synthesis, characterization, and in vivo biodistribution. J Mater Chem 2009, 19, 4029-4280. https://doi.org/10.1039/b910396c
  5. Choi KY, Min KH, Yoon HY, Kim K, Park JH, Kwon IC, Choi K, Jeong SY. PEGylation of hyaluronic acid nanoparticles improves tumor target ability in vivo. Biomaterials 2011, 32, 1880-1889. https://doi.org/10.1016/j.biomaterials.2010.11.010
  6. Collins MN, Birkinshaw C. Hyaluronic acid based scaffolds for tissue engineering-a review. Carbohyd Polym 2013, 92, 1262-1279. https://doi.org/10.1016/j.carbpol.2012.10.028
  7. Desai MP, Labhasetwar V, Amidon GL, Levy RJ. Gastrointestinal uptake of biodegradable microparticles: effect of particle size. Pharm Res 1996, 13, 1838-1845. https://doi.org/10.1023/A:1016085108889
  8. Desai MP, Labhasetwar V, Walter E, Levy RJ, Amidon GL. The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent. Pharm Res 1997, 14, 1568-1573. https://doi.org/10.1023/A:1012126301290
  9. Fraser JRE, Appelgren LE, Laurent TC. Tissue uptake of circulating hyaluronic acid: a whole body autoradiographic study. Cell Tissue Res 1983, 233, 285-293.
  10. Hwang HY, Kim IS, Kwon IC, Kim YH. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles. J Control Release 2008, 128, 23-31. https://doi.org/10.1016/j.jconrel.2008.02.003
  11. Joris F, Manshian BB, Peynshaert K, De Smedt SC, Braeckmans K, Soenen SJ. Assessing nanoparticle toxicity in cell-based assays: influence of cell culture parameters and optimized models for bridging the in vitro-in vivo gap. Chem Soc Rev 2013, 42, 8339-8359. https://doi.org/10.1039/c3cs60145e
  12. Lee H, Lee K, Kim IK, Park TG. Synthesis, characterization, and in vivo diagnostic applications of hyaluronic acid immobilized gold nanoprobes. Biomaterials 2008, 29, 4709-4718. https://doi.org/10.1016/j.biomaterials.2008.08.038
  13. Lee JS, Ji HJ, Chai H, Jeong JH, Nam SY, Yun YW, Lee BJ. Distribution and accumulation of Cy5.5-labeled hydrophobically modified glycol chitosan in mice. J Prev Vet Med 2015, 39, 48-57.
  14. Marquis BJ, Love SA, Braun KL, Haynes CL. Analytical methods to assess nanoparticle toxicity. Analyst 2009, 134, 425-439. https://doi.org/10.1039/b818082b
  15. Mironov V, Kasyano V, Shu XZ, Eisenberg C, Eisenberg L, Gonda S, Trusk T, Markwald RR, Prestwich GD. Fabrication of tubular tissue constructs by centrifugal casting of cells suspended in an in situ crosslinkable hyaluronangelatin hydrogel. Biomaterials 2005, 26, 7628-7635. https://doi.org/10.1016/j.biomaterials.2005.05.061
  16. Moghimi SM, Hunter AC, Murray JC. Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 2001, 53, 283-318.
  17. Nam JM, Thaxton CS, Mirkin CA. Nanoparticle-based biobar codes for the ultrasensitive detection of proteins. Science 2003, 301, 1884-1886. https://doi.org/10.1126/science.1088755
  18. Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003, 55, 329-347. https://doi.org/10.1016/S0169-409X(02)00228-4
  19. Rosler A, Vandermeulen GWM, Klok HA. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. Adv Drug Deliv Rev 2001, 53, 95-108. https://doi.org/10.1016/S0169-409X(01)00222-8
  20. Song U, Jun H, Waldman B, Roh J, Kim Y, Yi J, Lee EJ. Functional analyses of nanoparticle toxicity: a comparative study of the effects of TiO2 and Ag on tomatoes (Lycopersicon esculentum). Ecotoxicol Environ Saf 2013, 93, 60-67. https://doi.org/10.1016/j.ecoenv.2013.03.033
  21. Taton TA, Mirkin CA, Letsinger RL. Scanometric DNA array detection with nanoparticle probes. Science 2000, 289, 1757-1760. https://doi.org/10.1126/science.289.5485.1757
  22. Teijeiro C, McGlone A, Csaba N, Garcia-Fuentes M, Alonso MJ. Polysaccharide-based nanocarriers for drug delivery. In: Torchilin V (ed.). Handbook of Nanobiomedical Research: Fundamentals, Applications and Recent Developments. Vol. 1. 1st ed. pp. 235-278, World Scientific, Singapore, 2014.
  23. Thomas SN, Schudel A. Overcoming transport barriers for interstitial-, lymphatic-, and lymph node-targeted drug delivery. Curr Opin Chem Eng 2015, 7, 65-74. https://doi.org/10.1016/j.coche.2014.11.003
  24. Tiantian Y, Wenji Z, Mingshuang S, Rui Y, Shuangshuang S, Yuling M, Jianhua Y, Xinggang Y, Shujun W, Weisan P. Study on intralymphatic-targeted hyaluronic acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting. Int J Pharm 2014, 471, 245-257. https://doi.org/10.1016/j.ijpharm.2014.05.027
  25. Tripodo G, Trapani A, Torre ML, Giammona G, Trapani G, Mandracchia D. Hyaluronic acid and its derivatives in drug delivery and imaging: recent advances and challenges. Eur J Pharm Biopharm 2015, 97, 400-416. https://doi.org/10.1016/j.ejpb.2015.03.032
  26. Walkey CD, Olsen JB, Guo H, Emili A, Chan WCW. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 2012, 134, 2139-2147. https://doi.org/10.1021/ja2084338
  27. Zhang H, Ji Z, Xia T, Meng H, Low-Kam C, Liu R, Pokhrel S, Lin S, Wang X, Liao YP, Wang M, Li L, Rallo R, Damoiseaux R, Telesca D, Mdler L, Cohen Y, Zink JI, Nel AE. Use of metal oxide nanoparticle band gap to develop a predictive paradigm for oxidative stress and acute pulmonary inflammation. ACS Nano 2012, 6, 4349-4368. https://doi.org/10.1021/nn3010087